NEUROLEUKAEMIOSIS

NEUROLEUKAEMIOSIS was reported 4 times

NEUROLEUKAEMIOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Anthracycline Topoisomerase Inhibitor [EPC] 2 0.0008
1 BCL-2 Inhibitor [EPC] 1 0.0000
2 Glycopeptide Antibacterial [EPC] 1 0.0000
3 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
4 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
5 Azole Antifungal [EPC] 1 0.0000
6 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
7 Platinum-based Drug [EPC] 1 0.0000